There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:A61K48/00
Jump to navigation
Jump to search
Subcategories
This category has the following 29 subcategories, out of 29 total.
A
D
F
G
I
J
M
N
P
R
S
T
V
Y
Pages in category "A61K48/00"
The following 76 pages are in this category, out of 76 total.
1
- 17273688. BASE EDITING FOR TREATING HUTCHINSON-GILFORD PROGERIA SYNDROME simplified abstract (Vanderbilt University)
- 17999756. COMPOSITIONS AND METHODS FOR GENE EDITING simplified abstract (The Regents of the University of California)
- 18012164. GENE THERAPY FOR IMMUNO-ONCOLOGY APPLICATIONS simplified abstract (The Regents of the University of California)
- 18167598. Compositions and Methods of Treating Ocular Diseases simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18255951. TREATMENT OF CONGENITAL STATIONARY NIGHT BLINDNESS USING GENE THERAPY simplified abstract (CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE)
- 18264364. METHODS FOR PREVENTING CARDIAC OR SKELETAL DEFECTS IN DISEASES INCLUDING MUCOPOLYSACCHARIDOSES simplified abstract (REGENTS OF THE UNIVERSITY OF MINNESOTA)
- 18270014. Suppression-Replacement Gene Therapy simplified abstract (Mayo Foundation for Medical Education and Research)
- 18282421. Compositions and Methods for the Treatment of Conditions Associated with Nucleotide Repeat Expansion simplified abstract (The General Hospital Corporation)
- 18286984. PROMOTERS FOR VIRAL-BASED GENE THERAPY (The Regents of the University of California)
- 18289219. NOVEL AAV SEROTYPES DERIVED FROM A LIBRARY SCREEN simplified abstract (The Regents of the University of California)
- 18294594. ENGINEERED MUSCLE TARGETING COMPOSITIONS (MASSACHUSETTS INSTITUTE OF TECHNOLOGY)
- 18294594. ENGINEERED MUSCLE TARGETING COMPOSITIONS (President and Fellows of Harvard College)
- 18325332. Systemic Delivery of Polypeptides simplified abstract (Massachusetts Institute of Technology)
- 18352037. FUSION MOLECULES OF RATIONALLY-DESIGNED DNA-BINDING PROTEINS AND EFFECTOR DOMAINS simplified abstract (Duke University)
- 18428147. IMMOLATIVE CELL-PENETRATING COMPLEXES FOR NUCLEIC ACID DELIVERY TO THE LUNG simplified abstract (The Board of Trustees of the Leland Stanford Junior University)
- 18449940. DEAD GUIDES FOR CRISPR TRANSCRIPTION FACTORS simplified abstract (Massachusetts Institute of Technology)
- 18471738. RNA Containing Modified Nucleosides and Methods of Use Thereof simplified abstract (The Trustees of the University of Pennsylvania)
- 18482223. HIGH AFFINITY PD-1 AGENTS AND METHODS OF USE simplified abstract (The Board of Trustees of the Leland Stanford Junior University)
- 18544247. GENE THERAPY TREATMENT OF ATRIAL FIBRILLATION simplified abstract (NORTHWESTERN UNIVERSITY)
- 18546698. Systems and Methods to Enhance RNA Stability and Translation and Uses Thereof simplified abstract (The Board of Trustees of the Leland Stanford Junior University)
- 18547332. Compositions For and Methods of Improving Gene Therapy simplified abstract (Duke University)
- 18549503. SELECTIVE STIMULATION OF T CELLS IN SOLID TUMORS USING ONCOLYTIC VIRAL DELIVERY OF ORTHOGONAL IL-2 simplified abstract (The Regents of the University of California)
- 18552141. SYNTHETIC INTERMEMBRANE PROTEOLYSIS RECEPTORS FOR CUSTOM ANTIGEN-INDUCED TRANSCRIPTIONAL REGULATION simplified abstract (The Regents of the University of California)
- 18554627. GENE THERAPY FOR NEUROPROTECTION simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18554771. GENE THERAPY FOR ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18560348. MODIFIED MRNA, MODIFIED NON-CODING RNA, AND USES THEREOF simplified abstract (Massachusetts Institute of Technology)
- 18575597. ENHANCED EXPRESSION OF AN AROMATIC AMINO ACID DECARBOXYLASE (AADC) IN THE SUBSTANTIA NIGRA FOR THE TREATMENT OF PARKINSON'S DISEASE simplified abstract (NORTHWESTERN UNIVERSITY)
- 18602410. IMMOLATIVE CELL-PENETRATING COMPLEXES FOR NUCLEIC ACID DELIVERY simplified abstract (The Board of Trustees of the Leland Stanford Junior University)
- 18609414. HUMAN MESOTHELIN CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF (Novartis AG)
- 18609414. HUMAN MESOTHELIN CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF (The Trustees of the University of Pennsylvania)
- 18658077. METHODS OF TREATING MITOCHONDRIAL DISORDERS simplified abstract (The Regents of the University of California)
- 18668366. MICROPEPTIDES AND USE OF SAME FOR MODULATING GENE EXPRESSION simplified abstract (CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE)
- 18687571. METHODS FOR EVALUATING TREATMENTS FOR BESTROPHINOPATHIES (The Trustees of the University of Pennsylvania)
- 18704681. CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR KNOCKING OUT C5 (Regeneron Pharmaceuticals, Inc.)
- 18715587. SELF-ASSEMBLING VIRUS-LIKE PARTICLES FOR DELIVERY OF PRIME EDITORS AND METHODS OF MAKING AND USING SAME (President and Fellows of Harvard College)
- 18725289. IONIZABLE LIPIDS FOR MULTIPLE ORGAN TARGETING (Massachusetts Institute of Technology)
- 18746810. IONIZABLE AMINE LIPIDS AND LIPID NANOPARTICLES simplified abstract (Beam Therapeutics Inc.)
- 18751730. Methods and Compositions for RNA-Directed Target DNA Modification and For RNA-Directed Modulation of Transcription (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
- 18927415. AAV VECTORS ENCODING BASE EDITORS AND USES THEREOF (President and Fellows of Harvard College)
- 18948601. ENGINEERED PNMA PROTEINS AND DELIVERY SYSTEMS THEREOF (Massachusetts Institute of Technology)
- 18957358. MITOCHONDRIAL BASE EDITORS AND METHODS FOR EDITING MITOCHONDRIAL DNA (President and Fellows of Harvard College)
- 18963700. NANOPARTICLE NUCLEIC ACID CARRIER CONTAINING HYPERBRANCHED POLYLYSINE AND USE THEREOF (ZHEJIANG UNIVERSITY)
2
- 20240009284. METHOD AND COMPOSITION FOR TREATING ARGINASE 1 DEFICIENCY simplified abstract (Aerase, Inc.)
- 20240016894. METHODS AND MATERIALS FOR AMELIORATING CREATINE DEFICIENCY DISORDERS simplified abstract (The Regents of the University of California)
- 20240033378. ANTISENSE OLIGOMERS FOR TREATMENT OF NON-SENSE MEDIATED RNA DECAY BASED CONDITIONS AND DISEASES simplified abstract (STOKE THERAPEUTICS, INC.)
A
B
- Biotechnology patent applications on August 15th, 2024
- Biotechnology patent applications on May 30th, 2024
- Biotechnology patent applications on October 24th, 2024
- Biotechnology patent applications on October 3rd, 2024
- Biotechnology patent applications on September 19th, 2024
- Blockchain patent applications on April 11th, 2024
- Blockchain patent applications on April 18th, 2024
- Blockchain patent applications on February 1st, 2024
- Blockchain patent applications on January 11th, 2024
- Blockchain patent applications on January 18th, 2024
- Blockchain patent applications on March 28th, 2024
- Blockchain patent applications on March 7th, 2024
- Blockchain patent applications on May 16th, 2024
T
- The regents of the university of california (20240252678). SYNTHETIC EXOSOMES (SE) FOR CNS DELIVERY OF CRISPR FOR GENE EDITING IN BRAIN DISORDERS simplified abstract
- The regents of the university of california (20240293578). METHODS OF TREATING MITOCHONDRIAL DISORDERS simplified abstract
- The regents of the university of california (20240299586). NOVEL AAV SEROTYPES DERIVED FROM A LIBRARY SCREEN simplified abstract
- The regents of the university of california (20240309345). COMPOSITIONS AND METHODS FOR GENE EDITING simplified abstract
- The regents of the university of california (20250000945). Suppression of Neurodegeneration with Zinc Transporter Protein 7
- The regents of the university of california (20250092391). PROMOTERS FOR VIRAL-BASED GENE THERAPY
- The Regents of the University of California patent applications on August 1st, 2024
- The Regents of the University of California patent applications on February 13th, 2025
- The Regents of the University of California patent applications on January 2nd, 2025
- The Regents of the University of California patent applications on March 20th, 2025
- The Regents of the University of California patent applications on September 12th, 2024
- The Regents of the University of California patent applications on September 19th, 2024
- The Regents of the University of California patent applications on September 5th, 2024
